Ying Luo
CIK 1959160 · View on SEC EDGAR ↗
First SEC filing: May 6, 2026 · Latest: June 10, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | GYRE | S 10b5-1 | 10,136 | $8.04 | $81,493 | 2,565,226 Indirect | -0.39% | Disposed | -13.1% (price as of 2026-08-20) |
| May 5, 2026 | GYRE | S 10b5-1 | 179 | $8.01 | $1,434 | 2,575,362 Indirect | -0.01% | Disposed | -12.7% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 8, 2026 | GYRE | Stock Option (Right to Buy) | Common Stock (120,000) | $6.05 | June 8, 2036 | 120,000 | Acquired |
| Aug. 14, 2024 | GYRE | Stock Option (Right to Buy) | Common Stock (26,000) | $9.98 | Aug. 14, 2034 | 26,000 | Acquired |
| Nov. 20, 2023 | GYRE | Stock Option (Right to Buy) | Common Stock (2,262,755) | — | Oct. 31, 2030 | 2,262,755 | Acquired |
| Nov. 20, 2023 | GYRE | Stock Option (Right to Buy) | Common Stock (3,350,897) | — | Oct. 31, 2030 | 3,350,897 | Acquired |
| Oct. 31, 2023 | GYRE | Stock Option (Right to Buy) | Common Stock (1,866) | $6.93 | Oct. 31, 2033 | 1,866 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 8 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| May 7, 2026 | GYRE | Common Stock | 2,575,541 | Indirect |
| May 7, 2026 | GYRE | Stock Option (Right to Buy)→ Common Stock (475,300) | 475,300 | Direct |
| May 7, 2026 | GYRE | Stock Option (Right to Buy)→ Common Stock (237,650) | 237,650 | Direct |
| May 7, 2026 | GYRE | Stock Option (Right to Buy)→ Common Stock (3,378,763) | 3,378,763 | Direct |
| May 7, 2026 | GYRE | Stock Option (Right to Buy)→ Common Stock (199,626) | 199,626 | Direct |
| May 7, 2026 | GYRE | Stock Option (Right to Buy)→ Common Stock (988,624) | 988,624 | Direct |
| May 7, 2026 | GYRE | Stock Option (Right to Buy)→ Common Stock (235,273) | 235,273 | Direct |
| May 7, 2026 | GYRE | Stock Option (Right to Buy)→ Common Stock (2,262,755) | 2,262,755 | Indirect |